Picture of BioXcel Therapeutics logo

BTAIQ — BioXcel Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

BioXcel Therapeutics Inc reports results for the quarter ended in January - Earnings Summary

* BioXcel Therapeutics Inc  BTAI.OQ  reported a quarterly
adjusted
loss of 87 cents​​ per share for the quarter ended in January,
higher than the same quarter last year, when the company
reported EPS of $-1.84.  The mean expectation of six analysts
for the quarter was for a loss of 70 cents per share. Wall
Street expected results to range from -82 cents to -56 cents per
share.
    * Revenue rose 182.5% to $582.00 thousand from a year ago;
analysts expected $464.00 thousand. 
    * BioXcel Therapeutics Inc's reported EPS for the quarter
was a
loss of 87 cents​.
    * The company reported a quarterly loss of $26.79 million.
    * BioXcel Therapeutics Inc shares had fallen by 24.8% this
quarter and lost 28.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 27.8%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for BioXcel
Therapeutics Inc is $7.00 
This summary was machine generated from LSEG data May 9 at 01:53
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.70          -0.87          Missed
 Dec. 31 2023      -0.91          -0.76          Beat
 Sep. 30 2023      -1.30          -1.72          Missed
 Jun. 30 2023      -1.75          -1.83          Missed

Recent news on BioXcel Therapeutics

See all news